Harpoon Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Harpoon Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q3 2023.
  • Harpoon Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -46 %, a 22.1% increase year-over-year.
  • Harpoon Therapeutics, Inc. annual Return On Assets for 2022 was -68 %, a 14.7% decline from 2021.
  • Harpoon Therapeutics, Inc. annual Return On Assets for 2021 was -59.3 %, a 112% decline from 2020.
  • Harpoon Therapeutics, Inc. annual Return On Assets for 2020 was -27.9 %, a 19.2% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -46 +13 +22.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -53.6 -0.44 -0.83% Apr 1, 2023 Jun 30, 2023
Q1 2023 -67.7 -22 -48.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68 -8.69 -14.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59 -6 -11.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.1 -2.34 -4.61% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.7 +2.99 +6.14% Jan 1, 2022 Mar 31, 2022
Q4 2021 -59.3 -31.3 -112% Oct 1, 2021 Dec 31, 2021
Q3 2021 -53 -23.7 -80.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -50.8 -18.1 -55.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -48.7 -14.6 -42.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -27.9 +6.63 +19.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -29.4 +6.52 +18.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -32.7 Apr 1, 2020 Jun 30, 2020
Q1 2020 -34.2 Jan 1, 2020 Mar 31, 2020
Q4 2019 -34.6 Oct 1, 2019 Dec 31, 2019
Q3 2019 -35.9 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.